The total RNA content of N6-methyladenosine (M6A) and its key methyltransferase METTL3 expression in colon cancer tissues of oxaliplatin (OX) resistant patients were higher than those of OX-sensitive patients. The gene discussed is METTL3; the disease is malignant colon neoplasm.